Literature DB >> 22627081

Sundowning syndrome in aging and dementia: research in mouse models.

Tracy A Bedrosian1, Randy J Nelson.   

Abstract

Both normal aging and dementia are associated with altered circadian regulation of physiology and behavior. Elderly individuals and dementia patients commonly experience disrupted sleep-wake cycles, which may lead to psychomotor agitation, confusion, and wandering. These behaviors are disruptive to both patients and caregivers. Sundowning syndrome, which encompasses many of these behaviors, is characterized by a temporal pattern in the severity of symptoms, usually expressed as worse during the late afternoon or evening. Other than antipsychotic medications, off-label medications, and restraint, few treatment options are available. The aim of this paper is to review mouse studies of circadian behavioral disturbances relevant to sundowning, in order to determine potential models for studying the mechanisms of sundowning syndrome. The emergence of a useful mouse model should facilitate the development of novel therapeutic approaches.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22627081     DOI: 10.1016/j.expneurol.2012.05.005

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  24 in total

1.  Melatonin, the Hormone of Darkness: From Sleep Promotion to Ebola Treatment.

Authors:  Alina Masters; Seithikurippu R Pandi-Perumal; Azizi Seixas; Jean-Louis Girardin; Samy I McFarlane
Journal:  Brain Disord Ther       Date:  2014

Review 2.  Newly identified sleep-wake and circadian circuits as potential therapeutic targets.

Authors:  Anne Venner; William D Todd; Jimmy Fraigne; Hannah Bowrey; Ada Eban-Rothschild; Satvinder Kaur; Christelle Anaclet
Journal:  Sleep       Date:  2019-05-01       Impact factor: 5.849

Review 3.  Rhythms of life: circadian disruption and brain disorders across the lifespan.

Authors:  Ryan W Logan; Colleen A McClung
Journal:  Nat Rev Neurosci       Date:  2019-01       Impact factor: 34.870

4.  Medical hypothesis: Light at night is a factor worth considering in critical care units.

Authors:  Randy J Nelson; A Courtney DeVries
Journal:  Adv Integr Med       Date:  2017-12-21

Review 5.  Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology.

Authors:  Makoto Ishii; Costantino Iadecola
Journal:  Cell Metab       Date:  2015-09-10       Impact factor: 27.287

Review 6.  Development and Therapeutic Potential of Small-Molecule Modulators of Circadian Systems.

Authors:  Zheng Chen; Seung-Hee Yoo; Joseph S Takahashi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-10-02       Impact factor: 13.820

Review 7.  Time-of-day as a critical biological variable.

Authors:  Randy J Nelson; Jacob R Bumgarner; William H Walker; A Courtney DeVries
Journal:  Neurosci Biobehav Rev       Date:  2021-05-27       Impact factor: 9.052

Review 8.  Recent Progress in Non-motor Features of Parkinson's Disease with a Focus on Circadian Rhythm Dysregulation.

Authors:  Yufei Liu; Long Niu; Xinyao Liu; Cheng Cheng; Weidong Le
Journal:  Neurosci Bull       Date:  2021-06-15       Impact factor: 5.271

Review 9.  A time to fight: Circadian control of aggression and associated autonomic support.

Authors:  William D Todd; Natalia L Machado
Journal:  Auton Neurosci       Date:  2018-12-23       Impact factor: 2.355

10.  Pharmacological Rescue with SR8278, a Circadian Nuclear Receptor REV-ERBα Antagonist as a Therapy for Mood Disorders in Parkinson's Disease.

Authors:  Jeongah Kim; Inah Park; Sangwon Jang; Mijung Choi; Doyeon Kim; Woong Sun; Youngshik Choe; Ji-Woong Choi; Cheil Moon; Sung Ho Park; Han Kyoung Choe; Kyungjin Kim
Journal:  Neurotherapeutics       Date:  2022-03-23       Impact factor: 6.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.